Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05905484
Status:
COMPLETED
Last Update Posted:
2023-06-15
First Post:
2023-04-20
Brief Title:
Study of Bemnifosbuvir on Cardiac Repolarization in Healthy Subjects
Sponsor:
Atea Pharmaceuticals Inc
Organization:
Atea Pharmaceuticals Inc
Study Overview
Official Title:
A Phase 1 Double-blind Single-dose Randomized Placebo and Active-Controlled Four-Way Crossover Study Evaluating the Effects of Bemnifosbuvir on Cardiac Repolarization in Healthy Adult Subjects
Status:
COMPLETED
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the effects of Bemnifosbuvir on cardiac repolarization in healthy Adult Subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None